LABORATORIES:

Developmental Genetics
& Imprinting
 
Wolf Reik
Stephen Gaunt
Myriam Hemberger
Jon Houseley
Gavin Kelsey

Chromatin &
Gene Expression

Peter Fraser
Anne Corcoran
Sarah Elderkin
Cameron Osborne
Patrick Varga Weisz

Lymphocyte Signalling
& Development

Martin Turner
Geoff Butcher
Klaus Okkenhaug
Marc Veldhoen
Elena Vigorito

Molecular Signalling
Simon Cook
Tomas Bellamy
Martin Bootman
Michael Coleman
Keith Kendrick
Jennifer Pell
Llewelyn Roderick

Inositide
Len Stephens
Peter Evans
Phillip Hawkins
Sonja Vermeren
Nicholas Ktistakis
Raghu Padinjat
Michael Wakelam
Heidi Welch



Senior Affiliate Scientists
John Bicknell
Marianne Brüggemann
Piers Emson
Mike Taussig

Emeritus Fellow


Science Services

Postdoc Programme
Mentoring

Research into Action

Scientific Publications



Anne Corcoran Anne Corcoran
Tel. (01223) 496397

• Contact via email
• Group web pages
• Recent, selected Publications
• Group Members


Chromatin re-organisation regulates V(D)J recombination

Understanding the role of chromatin and chromosome structure in controlling gene expression during the development of the immune system is the focus of our research.

B lymphocytes are cells of the immune system that produce antibodies (immunoglobulins), which recognise and inactivate foreign antigens like bacteria. To cope with the enormous numbers of foreign antigens encountered during our lifespan, these cells must produce millions of different antibodies. Recombination or ‘shuffling' of genes in the immunoglobulin heavy chain (IgH) locus is the first step in generating this huge repertoire. Special ‘marks’ on the chromatin are thought to underlie the complex choice of gene segments in the multigenic immunoglobulin gene families, that can be recombined during B cell development to produce a large diversity of functional antibody molecules. This group studies non-coding RNA transcription (ie generation of transcripts that do not produce protein) in specific parts of the immunoglobulin cluster, which may play a directive role in V(D)J recombination, or mark epigenetic control regions.

The IgH locus contains 200 variable (V) genes, 12 diversity (D) genes, and 4 joining (J) genes, which are cut and pasted together (recombination) in many different combinations; a D and a J gene are spliced together first, followed by a V gene (Figure 1). Only one of each gene type is used in an individual cell and the resulting DNA sequence encodes a unique IgH, which is expressed with an Ig light chain as a unique highly specific antibody in each cell (Figure 1).

Our aim is to understand the chromatin remodelling mechanisms that open up the IgH locus in B cells to enable V(D)J recombination. Chromatin (DNA wrapped around nucleosomes composed of histone proteins) is a highly compacted structure and inaccessible in non-B cells. It must be unfolded to give access to the enzymes RAG1 and RAG2 that catalyse the DNA breaks (cutting) of VDJ rearrangement. If the locus isn't opened up enough, too few antibodies are made, resulting in immunodeficiency. Conversely if it's opened up excessively, or not closed down after recombination, inappropriate DNA breaks may occur, which may be repaired incorrectly causing B cell lymphomas.

Chromatin & Gene Expression banner